204 related articles for article (PubMed ID: 27975209)
1. Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia.
Craig CM; Liu LF; Deacon CF; Holst JJ; McLaughlin TL
Diabetologia; 2017 Mar; 60(3):531-540. PubMed ID: 27975209
[TBL] [Abstract][Full Text] [Related]
2. Postprandial plasma GLP-1 levels are elevated in individuals with postprandial hypoglycaemia following Roux-en-Y gastric bypass - a systematic review.
Jalleh RJ; Umapathysivam MM; Plummer MP; Deane A; Jones KL; Horowitz M
Rev Endocr Metab Disord; 2023 Dec; 24(6):1075-1088. PubMed ID: 37439960
[TBL] [Abstract][Full Text] [Related]
3. Differential effect of endogenous glucagon-like peptide-1 on prandial glucose counterregulatory response to hypoglycaemia in humans with and without bariatric surgery.
Honka H; Gastaldelli A; Pezzica S; Peterson R; DeFronzo R; Salehi M
Diabetes Obes Metab; 2024 Jun; 26(6):2476-2486. PubMed ID: 38558527
[TBL] [Abstract][Full Text] [Related]
4. Gastrectomy with Roux-en-Y reconstruction as a lean model of bariatric surgery.
Roberts GP; Kay RG; Howard J; Hardwick RH; Reimann F; Gribble FM
Surg Obes Relat Dis; 2018 May; 14(5):562-568. PubMed ID: 29548882
[TBL] [Abstract][Full Text] [Related]
5. Counter-regulatory responses to postprandial hypoglycaemia in patients with post-bariatric hypoglycaemia vs surgical and non-surgical control individuals.
Tripyla A; Herzig D; Reverter-Branchat G; Pavan J; Schiavon M; Eugster PJ; Grouzmann E; Nakas CT; Sauvinet V; Meiller L; Zehetner J; Giachino D; Nett P; Gawinecka J; Del Favero S; Thomas A; Thevis M; Dalla Man C; Bally L
Diabetologia; 2023 Apr; 66(4):741-753. PubMed ID: 36648553
[TBL] [Abstract][Full Text] [Related]
6. Canagliflozin or acarbose versus placebo to ameliorate post-bariatric hypoglycaemia - The HypoBar I randomized clinical trial protocol.
Lobato CB; Winding CT; Bojsen-Møller KN; Martinussen C; Veedfald S; Holst JJ; Madsbad S; Jørgensen NB; Dirksen C
Diabet Med; 2024 Jun; 41(6):e15320. PubMed ID: 38551152
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Glucagon-Like Peptide 1 Receptor Blockade on Glucagon-Induced Stimulation of Insulin Secretion.
Farahani RA; Egan AM; Welch AA; Laurenti MC; Cobelli C; Dalla Man C; Vella A
Diabetes; 2023 Apr; 72(4):449-454. PubMed ID: 36562995
[TBL] [Abstract][Full Text] [Related]
8. FXR-mediated epigenetic regulation of GLP-1R expression contributes to enhanced incretin effect in diabetes after RYGB.
Kong X; Feng L; Yan D; Li B; Yang Y; Ma X
J Cell Mol Med; 2024 Mar; 28(6):e16339. PubMed ID: 33611845
[TBL] [Abstract][Full Text] [Related]
9. Endogenous glucagon-like peptide 1 diminishes prandial glucose counterregulatory response to hypoglycemia after gastric bypass surgery.
Honka H; Gastaldelli A; Pezzica S; Peterson R; DeFronzo R; Salehi M
medRxiv; 2023 Dec; ():. PubMed ID: 37790563
[TBL] [Abstract][Full Text] [Related]
10. Cognition in patients with post-bariatric hypoglycemia.
Puleio A; Sheehan A; Musen G; Patti ME
Obesity (Silver Spring); 2024 Mar; 32(3):466-471. PubMed ID: 37667837
[TBL] [Abstract][Full Text] [Related]
11. Society for Endocrinology guidelines for the diagnosis and management of post-bariatric hypoglycaemia.
Hazlehurst J; Khoo B; Lobato CB; Ilesanmi I; Abbott S; Chan T; Pillai S; Maslin K; Purkayastha S; McGowan B; Andrews R; Tan TM
Endocr Connect; 2024 May; 13(5):. PubMed ID: 38451861
[TBL] [Abstract][Full Text] [Related]
12. How should we differentiate hypoglycaemia in non-diabetic patients?
Modestino MR; Iacono O; Ferrentino L; Lombardi A; De Fortuna U; Verdoliva R; De Luca M; Guardasole V
J Basic Clin Physiol Pharmacol; 2024 Apr; ():. PubMed ID: 38619602
[TBL] [Abstract][Full Text] [Related]
13. An unclear role for the GLP-1 metabolite GLP-1(9-36) in human islet physiology. Reply to Matveyenko A, Vella A [letter].
Gandasi NR; Rorsman P
Diabetologia; 2024 Apr; ():. PubMed ID: 38578450
[No Abstract] [Full Text] [Related]
14. Correction to: "The Role of GLP-1 in the Metabolic Success of Bariatric Surgery".
Endocrinology; 2024 Mar; 165(5):. PubMed ID: 38651299
[No Abstract] [Full Text] [Related]
15. Nonsuppressed Glucagon After Glucose Challenge as a Potential Predictor for Glucose Tolerance.
Wagner R; Hakaste LH; Ahlqvist E; Heni M; Machann J; Schick F; Van Obberghen E; Stefan N; Gallwitz B; Tuomi T; Häring HU; Groop L; Fritsche A
Diabetes; 2017 May; 66(5):1373-1379. PubMed ID: 27986831
[TBL] [Abstract][Full Text] [Related]
16. Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass.
Tharakan G; Behary P; Wewer Albrechtsen NJ; Chahal H; Kenkre J; Miras AD; Ahmed AR; Holst JJ; Bloom SR; Tan T
Eur J Endocrinol; 2017 Dec; 177(6):455-464. PubMed ID: 28855269
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and pharmacokinetics of subcutaneous exendin (9-39) in patients with post-bariatric hypoglycaemia.
Craig CM; Liu LF; Nguyen T; Price C; Bingham J; McLaughlin TL
Diabetes Obes Metab; 2018 Feb; 20(2):352-361. PubMed ID: 28776922
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of dapagliflozin over 1 year as add-on to insulin therapy in Japanese patients with type 2 diabetes: the DAISY (Dapagliflozin Added to patients under InSulin therapY) trial.
Araki E; Onishi Y; Asano M; Kim H; Yajima T
Diabetes Obes Metab; 2017 Apr; 19(4):562-570. PubMed ID: 27987240
[TBL] [Abstract][Full Text] [Related]
19. Factors Affecting Canagliflozin-Induced Transient Urine Volume Increase in Patients with Type 2 Diabetes Mellitus.
Tanaka H; Takano K; Iijima H; Kubo H; Maruyama N; Hashimoto T; Arakawa K; Togo M; Inagaki N; Kaku K
Adv Ther; 2017 Feb; 34(2):436-451. PubMed ID: 27981497
[TBL] [Abstract][Full Text] [Related]
20. Liraglutide in an Adolescent Population with Obesity: A Randomized, Double-Blind, Placebo-Controlled 5-Week Trial to Assess Safety, Tolerability, and Pharmacokinetics of Liraglutide in Adolescents Aged 12-17 Years.
Danne T; Biester T; Kapitzke K; Jacobsen SH; Jacobsen LV; Petri KCC; Hale PM; Kordonouri O
J Pediatr; 2017 Feb; 181():146-153.e3. PubMed ID: 27979579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
